Close
American Drug Delivery & Formulation Summit
Xylem
Press Releases

Lilly To Participate In Morgan Stanley Global Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Press Releases

Shilpa Biologicals Launches Integrated ADC Production Site in India

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd,...
Press Releases

CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing

CPHI Milan 2026, recognized as a premier global gathering...
Business & Industry

Sanofi Partners with Pangaea for AI-Driven AATD Detection

Pangaea Data (Pangaea), a provider of a guideline-configured AI...
- Advertisement -

Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015. Sue Mahony, Ph.D., senior vice president and president of Lilly Oncology and Richard Gaynor, M.D., senior vice president of product development and medical affairs for Lilly Oncology, will participate in a fireside chat at 3:30 p.m., Eastern Daylight Time.

A live audio webcast will be available on the “Webcasts & Presentations” section of Lilly’s investor website at http://investor.lilly.com/events.cfm. A replay of the fireside chat will be available for approximately 90 days.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector
Subscribe for Free

Latest stories

Previous article
U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for Empliciti (elotuzumab) for the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
Next article
Bristol-Myers Squibb and QIMR Berghofer Medical Research Institute Announce Worldwide Collaboration to Discover Novel Immuno-Oncology Antibodies

Related stories

Press Releases

Shilpa Biologicals Launches Integrated ADC Production Site in India

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd,...
Press Releases

CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing

CPHI Milan 2026, recognized as a premier global gathering...
Business & Industry

Sanofi Partners with Pangaea for AI-Driven AATD Detection

Pangaea Data (Pangaea), a provider of a guideline-configured AI...
Press Releases

Shilpa Biologicals Launches PartnerPower Platform for CDMOs

Shilpa Biologicals Pvt. Ltd. (SBPL) has introduced PartnerPower Platform,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
Formulation Analytics Accelerating Biologic Development

Formulation Analytics Accelerating Biologic Development

Polymer Science Advancing Sustained Drug Delivery

Polymer Science Advancing Sustained Drug Delivery